Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Lexicon Pharmaceuticals (Nasdaq: LXRX) has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference 2025. The company's management will deliver a presentation on Wednesday, April 9, at 8:00 a.m. ET.
Investors and interested parties can access both the live event and a replay of the presentation through the Events section of Lexicon's investor relations website at https://investors.lexpharma.com/.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha annunciato la sua prossima partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute 2025. La direzione dell'azienda presenterà un intervento mercoledì 9 aprile, alle 8:00 ET.
Gli investitori e le parti interessate possono accedere sia all'evento dal vivo che alla registrazione della presentazione attraverso la sezione Eventi del sito web delle relazioni con gli investitori di Lexicon all'indirizzo https://investors.lexpharma.com/.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha anunciado su próxima participación en la 24ª Conferencia Virtual Anual de Atención Médica de Needham 2025. La dirección de la empresa realizará una presentación el miércoles 9 de abril a las 8:00 a.m. ET.
Los inversores y partes interesadas pueden acceder tanto al evento en vivo como a la repetición de la presentación a través de la sección de Eventos en el sitio web de relaciones con inversores de Lexicon en https://investors.lexpharma.com/.
Lexicon Pharmaceuticals (Nasdaq: LXRX)는 2025년 제24회 니드햄 가상 의료 컨퍼런스에 참가할 예정이라고 발표했습니다. 회사 경영진은 4월 9일 수요일 오전 8시 ET에 발표를 진행할 것입니다.
투자자와 관심 있는 분들은 Lexicon의 투자자 관계 웹사이트의 이벤트 섹션을 통해 라이브 이벤트와 발표 재생 모두에 접근할 수 있습니다: https://investors.lexpharma.com/.
Lexicon Pharmaceuticals (Nasdaq: LXRX) a annoncé sa prochaine participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé 2025. La direction de l'entreprise fera une présentation le mercredi 9 avril à 8h00 ET.
Les investisseurs et les parties intéressées peuvent accéder à la fois à l'événement en direct et à la rediffusion de la présentation via la section Événements du site web des relations avec les investisseurs de Lexicon à l'adresse https://investors.lexpharma.com/.
Lexicon Pharmaceuticals (Nasdaq: LXRX) hat seine bevorstehende Teilnahme an der 24. jährlichen Needham virtuellen Gesundheitskonferenz 2025 angekündigt. Das Management des Unternehmens wird am Mittwoch, den 9. April, um 8:00 Uhr ET eine Präsentation halten.
Investoren und Interessierte können sowohl auf die Live-Veranstaltung als auch auf die Wiederholung der Präsentation über den Bereich Veranstaltungen der Investor-Relations-Website von Lexicon unter https://investors.lexpharma.com/ zugreifen.
- None.
- None.
THE WOODLANDS, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a presentation at the 24th Annual Needham Virtual Healthcare Conference 2025 on Wednesday, April 9, at 8:00 a.m. ET.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
When is Lexicon Pharmaceuticals (LXRX) presenting at the Needham Healthcare Conference 2025?
How can investors watch Lexicon's (LXRX) Needham Conference presentation?
Which healthcare conference is LXRX participating in April 2025?
Will there be a replay available of LXRX's Needham Conference presentation?
